Recruitment

Recruitment Status
Unknown status

Inclusion Criteria

Signed Informed consent and assent
No pharmacological treatment affecting lipid metabolism or glucose
No history of acute or prolonged immobilization
...
Signed Informed consent and assent
No pharmacological treatment affecting lipid metabolism or glucose
No history of acute or prolonged immobilization
Pc BMI ≥ 95 and <35kg/m2,
Normal aminotransferases
Patients of both sexes between 8 and 18 years old
No genetic diseases
No endocrine diseases, including diabetes mellitus
No systemic diseases

Summary

Conditions
Obesity
Type
Interventional
Phase
Phase 2
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Double (Participant, Investigator)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 8 years and 18 years
Gender
Both males and females

Inclusion Criteria

Signed Informed consent and assent
No pharmacological treatment affecting lipid metabolism or glucose
No history of acute or prolonged immobilization
...
Signed Informed consent and assent
No pharmacological treatment affecting lipid metabolism or glucose
No history of acute or prolonged immobilization
Pc BMI ≥ 95 and <35kg/m2,
Normal aminotransferases
Patients of both sexes between 8 and 18 years old
No genetic diseases
No endocrine diseases, including diabetes mellitus
No systemic diseases

Locations

Mexico, Distrito Federal, 06726
Mexico, Distrito Federal, 06726

Tracking Information

NCT #
NCT02063802
Collaborators
Hospital General de Mexico
Investigators
  • Principal Investigator: Nayely G Garibay, Pediatrician Hospital General de México Principal Investigator: Gloria E Queipo, M.Specialist Hospital General de México
  • Nayely G Garibay, Pediatrician Hospital General de México Principal Investigator: Gloria E Queipo, M.Specialist Hospital General de México